Voters should care about this bill because it directly addresses the growing threat of fake and substandard medications, which can be ineffective, contaminated, or contain dangerous ingredients, putting public health at risk. The current Fentanyl Sanctions Act is focused on a specific type of drug, but the problem of counterfeit drugs extends far beyond opioids to many other types of medications.

If this bill becomes law, the government would have more comprehensive tools to identify, track, and sanction those involved in the global trade of these dangerous substances, potentially making the drug supply safer for everyone. If it doesn't pass, the existing law's focus would remain narrower, and the specific threats posed by a wider array of counterfeit drugs and "copy-cat ingredients" would not be as directly or broadly addressed by this particular set of legal tools.